CVS Group (CVSG) Stock Rating Reaffirmed by Peel Hunt

Peel Hunt reissued their buy rating on shares of CVS Group (LON:CVSG) in a research note published on Friday, March 29th, ThisIsMoney.Co.Uk reports.

Separately, Royal Bank of Canada cut CVS Group to a sector performer rating and cut their price objective for the stock from GBX 1,180 ($15.42) to GBX 600 ($7.84) in a research report on Wednesday, January 30th.

CVS Group stock traded down GBX 2 ($0.03) during trading on Friday, hitting GBX 591 ($7.72). 207,520 shares of the company were exchanged, compared to its average volume of 234,115. CVS Group has a 52 week low of GBX 362.40 ($4.74) and a 52 week high of GBX 1,191 ($15.56). The company has a market capitalization of $416.06 million and a P/E ratio of 62.87. The company has a current ratio of 1.13, a quick ratio of 0.89 and a debt-to-equity ratio of 83.39.

In other CVS Group news, insider Richard A. Connell acquired 10,000 shares of the business’s stock in a transaction on Wednesday, January 30th. The shares were acquired at an average price of GBX 407 ($5.32) per share, with a total value of £40,700 ($53,181.76).

CVS Group Company Profile

CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services.

Recommended Story: Trading Strategy Methods for Individual Investors

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.